Cherry Tree Wealth Management
LRMR icon

Cherry Tree Wealth Management’s Larimar Therapeutics LRMR Stock Holding History

Cherry Tree Wealth Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.8K Hold
15,264
– – 0.01% 283
2026
Q2 		$46.6K Hold
15,264
– – 0.01% 286
2026
Q1 		$68.7K Hold
15,264
– – 0.01% 243
2025
Q4 		$58.2K Buy
15,264
+2,000
+15% +$7.78K 0.01% 256
2025
Q3 		$42.8K Buy
13,264
+2,646
+25% +$9.9K 0.01% 270
2025
Q2 		$30.7K Buy
+10,618
New +$24.6K 0.01% 292

Other funds holding LRMR

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Next Level Private
Next Level Private Harrison, New York $520M AUM 19.06% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Cherry Tree Wealth Management's LRMR Position: Q3 2026 in Review

Cherry Tree Wealth Management held its Larimar Therapeutics (LRMR) position steady in Q3 2026 at 15,264 shares worth $48.8K. The position accounts for 0.01% of the portfolio, ranked #283.

Cherry Tree Wealth Management first reported a position in LRMR in Q2 2025 and has held it in 6 quarters since. The position peaked at $68.7K in Q1 2026. 26 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.

  • Cherry Tree Wealth Management held 15,264 shares of Larimar Therapeutics worth $48.8K as of Q3 2026.
  • Cherry Tree Wealth Management left its Larimar Therapeutics share count unchanged in Q3 2026.
  • Larimar Therapeutics made up 0.01% of Cherry Tree Wealth Management's portfolio in Q3 2026, its #283 holding.
  • Cherry Tree Wealth Management first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Cherry Tree Wealth Management's Larimar Therapeutics position peaked at $68.7K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.